Sens. Float Automatic Biosimilar Interchangeable Label
By Theresa Schliep · June 5, 2025, 9:05 PM EDT
A bipartisan group of U.S. senators has reintroduced legislation that would reduce what the lawmakers called barriers to accessing lower-cost versions of biologic drugs, making an adjustment to how biosimilars are...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login